Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Articles tagged with "Treatment"

ACR Advances Legislation to Increase Patients’ Access to Biologic Drugs to Treat Rheumatoid Arthritis and Other Conditions

Staff  |  March 1, 2013

The Patients’ Access to Treatments Act of 2013 would prevent insurance companies from tacking on an additional cost-sharing fee for the specialty medications

ACR/ARHP Annual Meeting 2012: Risk of Immunosuppression from Rheumatic Disease Therapies Poses Challenge for Rheumatologists

Susan Bernstein  |  March 1, 2013

Therapies can raise patients’ risk of contracting tuberculosis or other infectious diseases, complicating treatment

ACR/ARHP Annual Meeting 2012: Physicians Find Treatment Options Limited for Scleroderma Bowel Disease

Thomas R. Collins  |  March 1, 2013

With few proven medical treatments for scleroderma bowel disease, physicians often recommend a lifestyle change for patients as a first treatment option

What Mick Jagger Can Teach Us About Growing Old Gracefully

Simon M. Helfgott, MD  |  February 1, 2013

Preventive lifestyle behaviors, including regular exercise, can compress morbidity and disability to the very end of our lives, say rheumatologists

ACR/ARHP Annual Meeting 2012: Understanding Pain Signals May Pave Path to More Effective Therapies

Susan Bernstein  |  February 1, 2013

The ability to differentiate the types of pain affiliated with rheumatic diseases can help rheumatologists better diagnose and treat patients

ACR/ARHP Annual Meeting 2012: Will Novel Strategies Lead to Breakthroughs in Treating Osteoarthritis?

Susan Bernstein  |  February 1, 2013

 

ACR/ARHP Annual Meeting 2012: New Research Into Stem Cell Therapy and Drugs May Lead to Breakthrough Treatments for Osteoarthritis

Susan Bernstein  |  February 1, 2013

Novel strategies for treating osteoarthritis aim to relieve pain, rebuild or replenish deteriorated cartilage and bone, or to replace the joint through surgery

Letter: Praise for SAPHO Syndrome Article

Nils Erikson, MD, and Marcel Francis Kahn, MD  |  February 1, 2013

After reading your article on SAPHO, I may get a better treatment plan for my patient; thanks for drawing the attention of American College of Rheumatology members to an obscure condition that can vex patients and clinicians

ACR/ARHP Annual Meeting 2012: Cyclophosphamide and Rituximab Both Viable Treatment Options for ANCA-Associated Vasculitis

Mary Beth Nierengarten  |  February 1, 2013

Rituximab established as the drug of choice in patients with severe disease relapse, though cyclophosphamide may still play an important role for some patients, say rheumatologists

ACR/ARHP Annual Meeting 2012: Early Signs of Rheumatoid Arthritis May Appear Outside the Joints

Mary Beth Nierengarten  |  February 1, 2013

Evidence that suggests rheumatoid arthritis (RA) starts in mucosal sites such as the oral cavity and lung may lead to improved treatment and prevention of the disease

  • « Previous Page
  • 1
  • …
  • 26
  • 27
  • 28
  • 29
  • 30
  • …
  • 41
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences